Literature DB >> 16220973

G-protein-coupled receptor affinity prediction based on the use of a profiling dataset: QSAR design, synthesis, and experimental validation.

Catherine Rolland1, Rafael Gozalbes, Eric Nicolaï, Marie-France Paugam, Laurent Coussy, Frédérique Barbosa, Dragos Horvath, Frédéric Revah.   

Abstract

A QSAR model accounting for "average" G-protein-coupled receptor (GPCR) binding was built from a large set of experimental standardized binding data (1939 compounds systematically tested over 40 different GPCRs) and applied to the design of a library of "GPCR-predicted" compounds. Three hundred and sixty of these compounds were randomly selected and tested in 21 GPCR binding assays. Positives were defined by their ability to inhibit by more than 70% the binding of reference compounds at 10 microM. A 5.5-fold enrichment in positives was observed when comparing the "GPCR-predicted" compounds with 600 randomly selected compounds predicted as "non-GPCR" from a general collection. The model was efficient in predicting strongest binders, since enrichment was greater for higher cutoffs. Significant enrichment was also observed for peptidic GPCRs and receptors not included to develop the QSAR model, suggesting the usefulness of the model to design ligands binding with newly identified GPCRs, including orphan ones.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16220973     DOI: 10.1021/jm0500673

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Defining scaffold geometries for interacting with proteins: geometrical classification of secondary structure linking regions.

Authors:  Tran T Tran; Christina Kulis; Steven M Long; Darryn Bryant; Peter Adams; Mark L Smythe
Journal:  J Comput Aided Mol Des       Date:  2010-09-23       Impact factor: 3.686

2.  Mappability of drug-like space: towards a polypharmacologically competent map of drug-relevant compounds.

Authors:  Pavel Sidorov; Helena Gaspar; Gilles Marcou; Alexandre Varnek; Dragos Horvath
Journal:  J Comput Aided Mol Des       Date:  2015-11-12       Impact factor: 3.686

3.  Balancing focused combinatorial libraries based on multiple GPCR ligands.

Authors:  Farhad Soltanshahi; Tamsin E Mansley; Sun Choi; Robert D Clark
Journal:  J Comput Aided Mol Des       Date:  2006-10-13       Impact factor: 3.686

Review 4.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

5.  Theoretical analysis of somatostatin receptor 5 with antagonists and agonists for the treatment of neuroendocrine tumors.

Authors:  Santhosh Kumar Nagarajan; Sathya Babu; Thirumurthy Madhavan
Journal:  Mol Divers       Date:  2017-02-02       Impact factor: 2.943

Review 6.  Predicting monoamine oxidase inhibitory activity through ligand-based models.

Authors:  Santiago Vilar; Giulio Ferino; Elias Quezada; Lourdes Santana; Carol Friedman
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

7.  Virtual screening of GPCRs: an in silico chemogenomics approach.

Authors:  Laurent Jacob; Brice Hoffmann; Véronique Stoven; Jean-Philippe Vert
Journal:  BMC Bioinformatics       Date:  2008-09-06       Impact factor: 3.169

8.  Comparative docking study of anibamine as the first natural product CCR5 antagonist in CCR5 homology models.

Authors:  Guo Li; Kendra M Haney; Glen E Kellogg; Yan Zhang
Journal:  J Chem Inf Model       Date:  2009-01       Impact factor: 4.956

9.  Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study.

Authors:  Gugan Kothandan; Changdev G Gadhe; Seung Joo Cho
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.